Literature DB >> 8031042

Intestinal elimination of ciprofloxacin in rabbits.

J Ramon1, S Dautrey, R Farinoti, C Carbon, E Rubinstein.   

Abstract

The intestinal transepithelial elimination of ciprofloxacin was studied in a rabbit model. Jejunal, ileal, and cecal segments along with their intact blood vessels were isolated and perfused, and their contents were collected over a 120-min period following administration of a single parenteral dose of 27 mg of ciprofloxacin per kg of body weight. The intestinal elimination rates of ciprofloxacin were 0.126 +/- 0.084, 0.235 +/- 0.22, and 0.11 +/- 0.084 micrograms.min-1.cm-2 for the jejunal, ileal, and cecal segments, respectively. The calculated fractions of ciprofloxacin eliminated were 3.3 mg from the jejunum and 13.8 mg from the ileum, representing 19% of the administered dose. Additional amounts of 2.5 to 3.7 mg or 4.9 to 7.3% of the administered dose were eliminated from the cecum. Elimination was probably not due to a passive diffusion process but rather due to an active transepithelial transport. This intestinal elimination pattern of ciprofloxacin may explain the unusual activity of the fluoroquinolones in modifying the intestinal flora.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031042      PMCID: PMC284538          DOI: 10.1128/AAC.38.4.757

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Male-to-female transmission of human immunodeficiency virus infection by oro-genital sex.

Authors:  V Puro; P Narciso; E Girardi; L Antonelli; M Zaccarelli; G Visco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-01       Impact factor: 3.267

2.  Gastrointestinal secretion of ciprofloxacin. Evaluation of the charcoal model for investigations in healthy volunteers.

Authors:  F Sörgel; K G Naber; U Jaehde; A Reiter; R Seelmann; G Sigl
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

Review 3.  Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.

Authors:  F Sorgel; K G Naber; M Kinzig; G Mahr; P Muth
Journal:  Am J Med       Date:  1991-12-30       Impact factor: 4.965

4.  Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.

Authors:  W Brumfitt; I Franklin; D Grady; J M Hamilton-Miller; A Iliffe
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

Review 5.  Enhancement of xenobiotic elimination: role of intestinal excretion.

Authors:  Z H Israili; P G Dayton
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

6.  Pharmacokinetics of cefuroxime and ciprofloxacin in gastric mucosa: comparison to in vitro inhibitory concentrations against Helicobacter pylori.

Authors:  T U Westblom; D E Duriex
Journal:  Microbiologica       Date:  1991-01

7.  Intestinal secretion of erythromycin base.

Authors:  D R Holland; J F Quay
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

8.  Role of intestinal excretion in the effect of subcutaneously administered sedecamycin on cecal infection caused by Treponema hyodysenteriae in mice.

Authors:  T Hayashi; J Okada; S Kondo; T Yamazaki
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

9.  Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens.

Authors:  T U Westblom; D E Duriex; E Madan; R B Belshe
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

  9 in total
  6 in total

1.  Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate.

Authors:  W A Krueger; G Ruckdeschel; K Unertl
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Excretion of ciprofloxacin into the large bowel of the rabbit.

Authors:  J Ramon; S Dautrey; R Farinoti; C Carbon; E Rubinstein
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

3.  Intestinal elimination of sparfloxacin, fleroxacin, and ciprofloxacin in rats.

Authors:  E Rubinstein; S Dautrey; R Farinoti; L St Julien; J Ramon; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 4.  Role of quinolones in the treatment of diarrhoeal diseases.

Authors:  H E Akalin
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 5.  Absorption interactions with fluoroquinolones. 1995 update.

Authors:  B M Lomaestro; G R Bailie
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

6.  Sex Difference of Effect of Sophora flavescens on Gut Microbiota in Rats.

Authors:  Xueqing Duan; Xin Xie; Chen Zhu; Zhixuan Duan; Rui Chen; Jun Xu; Qi Zhang; Qi Yu; Weiyi Tian
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-15       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.